TG THERAPEUTICS IN revenue breakdown overview

TG THERAPEUTICS IN revenue for the last year amounted to 196.73 M CHF, the most of which — 196.73 M CHF — came from its highest performing source at the moment, Novel Treatments for B-cell Diseases, the year earlier bringing 2.58 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought TG THERAPEUTICS IN 196.73 M CHF, and the year before that — 2.58 M CHF.